Which among the following is human Insulin analogue?
**Core Concept**
Human Insulin analogues are modified versions of human insulin to achieve specific therapeutic goals, such as rapid onset of action, longer duration of action, or reduced hypoglycemia risk. They mimic the natural insulin action in the body but with altered pharmacokinetic properties.
**Why the Correct Answer is Right**
Glargine insulin is a long-acting human Insulin analogue that provides a smooth, flat action profile for up to 24 hours. It is designed to be absorbed slowly from the injection site, leading to a gradual increase in insulin levels in the bloodstream. This results in a basal insulin effect that helps to control blood glucose levels throughout the day. Glargine insulin is not prone to hypoglycemia due to its flat action profile and is often used in basal insulin therapy regimens.
**Why Each Wrong Option is Incorrect**
**Option A:** Lispro insulin is a rapid-acting human Insulin analogue, which starts working within 15 minutes after injection and peaks in 1 hour. It is not a long-acting analogue like Glargine.
**Option B:** Aspart insulin is another rapid-acting human Insulin analogue, similar to Lispro, with a fast onset of action but not a long-acting analogue.
**Option C:** Detemir insulin is a long-acting human Insulin analogue but has a different mechanism of action compared to Glargine, with a more rapid onset of action and a shorter duration of action.
**Clinical Pearl / High-Yield Fact**
Human Insulin analogues have revolutionized the management of diabetes mellitus by providing more flexibility and convenience in insulin therapy regimens.
**Correct Answer:** C. Detemir insulin is another long-acting analogue, however the question is asking for Glargine.